Mgr. Hana Kubušová, Ph.D.
Researcher, Lenka Zdražilová Dubská Research Group: Innovative ATMP for rare diseases
Correspondence Address:
Palachovo nám. 726/3, 625 00 Brno
Office: bldg. C03/335
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 7641 |
---|---|
E‑mail: |
Inactive employment status
Total number of publications: 22
2020
-
Ferrocenes as new anticancer drug candidates: Determination of the mechanism of action
European Journal of Pharmacology, year: 2020, volume: 867, edition: JAN 15 2020, DOI
-
Harmless glucose‐modified ruthenium complexes suppressing cell migration of highly invasive cancer cell lines
Applied Organometallic Chemistry, year: 2020, volume: 34, edition: 1, DOI
-
Mesoporous silica nanoparticles functionalized with a dialkoxide diorganotin(IV) compound: In search of more selective systems against cancer cells.
Microporous and Mesoporous Materials, year: 2020, volume: 300, edition: JUN 15 2020, DOI
-
The Cytotoxic Effect of Newly Synthesized Ferrocenes against Cervical Carcinoma Cells Alone and in Combination with Radiotherapy.
Applied Sciences, year: 2020, volume: 10, edition: 11
2019
-
Electrochemical Study of Highly Substituted Titanocene Dihalides
Electroanalysis, year: 2019, volume: 31, edition: 10, DOI
-
Pokroky ve využití organokovových sloučenin při vývoji protinádorových léčiv
Klinická onkologie, year: 2019, DOI
-
The cytotoxic effect of ferrocene derivatives in combination with radiotherapy against cervical carcinoma cells
Year: 2019, type: Appeared in Conference without Proceedings
-
Vliv kombinace nově syntetizovaných ferrocenů a radioterapie na nádorové buněčné linie karcinomu děložního hrdla
Year: 2019, type: Appeared in Conference without Proceedings
2018
-
Ferrocenes as Potential Anticancer Drugs: Determination of The Mechanism of Action
Year: 2018, type: Conference abstract
-
Ferroptóza jako nový typ buněčné smrti a její role v léčbě rakoviny
Klinická onkologie, year: 2018, DOI